salicylic acid has been researched along with aminolevulinic acid in 51 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.96) | 18.2507 |
| 2000's | 5 (9.80) | 29.6817 |
| 2010's | 32 (62.75) | 24.3611 |
| 2020's | 13 (25.49) | 2.80 |
| Authors | Studies |
|---|---|
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
| Khachemoune, A; Lichon, V | 1 |
| Du, D; He, P; Wei, P; Yu, Z; Zhang, C | 1 |
| Lichon, V; Means, AD; Monaghan, D; O'Keefe, P; Sisto, K; Tung, R | 1 |
| Bosselmann, I; Enk, AH; Fink, C; Gholam, P | 1 |
| Nissen, CV; Philipsen, PA; Wiegell, SR; Wulf, HC | 1 |
| Cai, C; Chai, Q; Cheng, C; Guo, W; Shang, X; Wang, X; Wu, S; Zhu, G | 1 |
| Andersen, F; Bjerring, P; Haedersdal, M; Lerche, CM; Pihl, C | 1 |
| Fink-Puches, R; Kerl, H; Reimann-Weber, A; Wolf, P | 1 |
| Burden, AD; Morton, CA | 1 |
| Atkin, D; Fitzpatrick, R; Morhenn, V; Piacquadio, D; Smith, S | 1 |
| Hanada, K; Harada, K; Katoh, S; Moritsugu, R; Nakano, H; Tamai, K; Tanaka, M; Umegaki, N | 1 |
| Frias, MP; Gilaberte, Y; Rezusta, A; Vera-Alvarez, J | 1 |
| Apalla, Z; Chovarda, E; Devliotou-Panagiotidou, D; Ioannides, D; Lefaki, I; Sotiriou, E | 1 |
| Gao, T; Li, Q; Long, HA; Ujiie, H | 1 |
| Letada, PR; Masters, R; Satter, EK; Shumaker, PR; Uebelhoer, NS | 1 |
| Apalla, Z; Chovarda, E; Goussi, C; Ioannides, D; Sotiriou, E; Trigoni, A | 1 |
| Skødt, V; Wiegell, SR; Wulf, HC | 1 |
| Enzmann, H; Hoppe, U; Kiely, P; O'Dea, G; Pignatti, F; Salmon, P; Salmonson, T; Straube, M; Tzogani, K | 1 |
| Buinauskaite, E; Buinauskiene, J; Valiukeviciene, S; Zalinkevicius, R | 1 |
| Buinauskaite, E; Buinauskiene, J; Maciulaitis, R; Valiukeviciene, S | 1 |
| Tolley, K; Vegter, S | 1 |
| Graf, B; Gruber, M; Hansen, E; Heinlin, J; Horner, C; Karrer, S; Kerscher, C; Klein, A; Koller, M; Landthaler, M; Szeimies, RM; Werner, A; Zeman, F | 1 |
| Boccaletti, V; Conti, ML; Cortelazzi, C; Di Nuzzo, S; Fabrizi, G; Feliciani, C; Montanari, P; Pagliarello, C; Zucchi, A | 1 |
| Reygagne, P; Youssef, AA | 1 |
| Arisi, M; Calzavara-Pinton, P; Fabiano, A; Zane, C | 1 |
| Bierman, D; Gandy, J; Labadie, B; Zachary, C | 1 |
| Galimberti, GN | 1 |
| Bieliauskiene, G; Heerfordt, IM; Wulf, HC | 1 |
| Apalla, Z; Ioannides, D; Kirmanidou, E; Lallas, A; Lazaridou, E; Sideris, N; Sotiriou, E; Vakirlis, E; Vrani, F | 1 |
| Bancalari, E; Bernia, E; Calomarde, L; Diago, A; Guillén, C; Kindem, S; Llombart, B; Nagore, E; Requena, C; Sanmartín, O; Serra-Guillén, C; Serra-Guillén, I | 1 |
| Béhal, H; Deleporte, P; Duhamel, A; Kerob, D; Lecomte, F; Maire, C; Mordon, S; Mortier, L; Thecua, E; Vicentini, C; Vignion-Dewalle, AS | 1 |
| Baptista, AM; Campos, MAC; Menezes, NMBVN; Sousa, ACDS | 1 |
| Alkhars, A; Korsaga-Some, N; Machet, L; Safar, R; Tallegas, M | 1 |
| Imhof, L; Ramelyte, E | 1 |
| Morton, CA | 1 |
| Fargnoli, MC; Gutiérrez García-Rodrigo, C; Pellegrini, C; Piccioni, A; Tambone, S | 1 |
| Borgia, F; Cannavò, SP; Giuffrida, R; Marafioti, I; Riso, G | 1 |
| Huang, R; Li, W; Lu, J; Wu, W; Zheng, W | 1 |
| Gjersvik, P; Helsing, P; Mørk, G; Rizvi, SM; Veierød, MB | 1 |
| Garnacho-Sucedo, G; Jiménez-Nájar, F; Salido-Vallejo, R; Vélez, A | 1 |
| Abdalla, BMZ; Garcia Morales, A; Krutman Zveibil, D; Paschoal, FM; Simas Pedreiro, B | 1 |
| Meierhofer, C; Radakovic, S; Silic, K; Tanew, A; Urban, MV | 1 |
| Castagnetti, E; Cortelazzi, C; Di Nuzzo, S; Odorici, G; Pellacani, G | 1 |
| Arisi, M; Calzavara-Pinton, PG; Guasco Pisani, E; Rossi, MT; Rovati, C; Spiazzi, L; Tomasi, C; Venturini, M; Venturuzzo, A | 1 |
| Cao, Z; Hu, W; Liu, X; Wang, P; Wang, X; Zhang, G; Zhang, L; Zhang, Y; Zhou, Z | 1 |
| Ag, S; Er, O; Ha, M; Lpf, A; Mb, R; Mmc, M; Mr, G | 1 |
| Bai-Habelski, JC; Medrano, K; Palacio, A; Reinhold, U | 1 |
| Bhargava, S; Cunha, PR; Kroumpouzos, G; Misitzis, A | 1 |
| Bernal-Masferrer, L; Cerro-Muñoz, P; García-Gil, MF; Gilaberte, Y; Gracia-Cazaña, T; Navarro-Bielsa, A | 1 |
| Kammer, M; Radakovic, S; Sator, PG; Silic, K; Tanew, A | 1 |
3 review(s) available for salicylic acid and aminolevulinic acid
| Article | Year |
|---|---|
Plantar warts: a focus on treatment modalities.
Topics: Aminolevulinic Acid; Bleomycin; Cantharidin; Cryotherapy; Foot Dermatoses; Humans; Immunotherapy; Irritants; Keratolytic Agents; Laser Therapy; Patient Education as Topic; Photochemotherapy; Photosensitizing Agents; Recurrence; Salicylic Acid; Skin Care; Warts | 2007 |
Improving the efficacy of photodynamic therapy for actinic keratosis: A comprehensive review of pharmacological pretreatment strategies.
Topics: Aminolevulinic Acid; Diclofenac; Fluorouracil; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Retinoids; Salicylic Acid; Treatment Outcome; Urea; Vitamin D | 2023 |
A network meta-analysis of the relative efficacy of treatments for actinic keratosis of the face or scalp in Europe.
Topics: Aminolevulinic Acid; Clinical Trials as Topic; Europe; Face; Humans; Keratosis, Actinic; Photochemotherapy; Scalp; Treatment Outcome | 2014 |
20 trial(s) available for salicylic acid and aminolevulinic acid
| Article | Year |
|---|---|
Short incubation PDT versus 5-FU in treating actinic keratoses.
Topics: Administration, Cutaneous; Aminolevulinic Acid; Antimetabolites, Antineoplastic; Face; Female; Fluorouracil; Humans; Keratosis; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Severity of Illness Index; Treatment Outcome | 2003 |
Skin cancer: preventive photodynamic therapy in patients with face and scalp cancerization. A randomized placebo-controlled study.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Facial Neoplasms; Female; Head and Neck Neoplasms; Humans; Keratosis, Actinic; Male; Middle Aged; Neoplasms, Second Primary; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms | 2010 |
Single vs. fractionated photodynamic therapy for face and scalp actinic keratoses: a randomized, intraindividual comparison trial with 12-month follow-up.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp | 2012 |
The European Medicines Agency approval of 5-aminolaevulinic acid (Ameluz) for the treatment of actinic keratosis of mild to moderate intensity on the face and scalp: summary of the scientific assessment of the Committee for Medicinal Products for Human Us
Topics: Administration, Topical; Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Face; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Survival Rate; Treatment Outcome; Young Adult | 2014 |
Pain during topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid and red light source: randomized controlled trial.
Topics: Aged; Aminolevulinic Acid; Animals; Face; Female; Humans; Male; Pain; Pain Measurement; Photochemotherapy; Photosensitivity Disorders; Photosensitizing Agents; Prospective Studies; Scalp | 2013 |
Topical photodynamic therapy of actinic keratoses with 5-aminolevulinic acid: randomized controlled trial with six months follow-up.
Topics: Aminolevulinic Acid; Face; Follow-Up Studies; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp; Treatment Outcome | 2014 |
Comparing cold-air analgesia, systemically administered analgesia and scalp nerve blocks for pain management during photodynamic therapy for actinic keratosis of the scalp presenting as field cancerization: a randomized controlled trial.
Topics: Administration, Oral; Aged; Aminolevulinic Acid; Analgesia; Analgesics, Opioid; Analysis of Variance; Anti-Inflammatory Agents, Non-Steroidal; Cold Temperature; Dipyrone; Facial Dermatoses; Forehead; Hemodynamics; Humans; Injections, Intravenous; Keratosis, Actinic; Male; Middle Aged; Nerve Block; Ophthalmic Nerve; Pain; Pain Measurement; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pirinitramide; Quality of Life; Scalp; Scalp Dermatoses; Trochlear Nerve | 2015 |
A Randomized Split-Face Clinical Trial of Photodynamic Therapy with Methyl Aminolevulinate versus Ingenol Mebutate Gel for the Treatment of Multiple Actinic Keratoses of the Face and Scalp.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminolevulinic Acid; Diterpenes; Face; Facial Dermatoses; Female; Follow-Up Studies; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Remission Induction; Retrospective Studies; Scalp; Scalp Dermatoses; Skin; Treatment Outcome | 2016 |
Calcipotriol as pretreatment prior to daylight-mediated photodynamic therapy in patients with actinic keratosis: A case series.
Topics: Adult; Aged; Aminolevulinic Acid; Calcitriol; Dermatologic Agents; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Remission Induction; Scalp; Sunlight | 2018 |
Protoporphyrin IX formation after application of methyl aminolevulinate on the face and scalp with and without prior curettage.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Curettage; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Protoporphyrins; Scalp | 2018 |
Short incubation fractional CO
Topics: Administration, Cutaneous; Aged; Aged, 80 and over; Aminolevulinic Acid; Carcinoma, Basal Cell; Carcinoma, Squamous Cell; Combined Modality Therapy; Facial Neoplasms; Female; Humans; Keratosis, Actinic; Lasers, Gas; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Absorption; Skin Neoplasms; Time Factors | 2019 |
A randomized intraindividual comparative study of methyl-5-aminolaevulinate vs. 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) in photodynamic therapy for actinic keratosis of the face and scalp.
Topics: Administration, Cutaneous; Aged; Aminolevulinic Acid; Erythema; Face; Female; Humans; Keratosis, Actinic; Male; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Skin; Treatment Outcome; Visual Analog Scale | 2018 |
Photodynamic therapy for actinic keratosis of the forehead and scalp: a randomized, controlled, phase II clinical study evaluating the noninferiority of a new protocol involving irradiation with a light-emitting, fabric-based device (the Flexitheralight p
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Facial Dermatoses; Female; Forehead; Humans; Keratosis, Actinic; Male; Middle Aged; Pain Measurement; Pain, Procedural; Patient Reported Outcome Measures; Photochemotherapy; Photosensitizing Agents; Scalp; Scalp Dermatoses; Severity of Illness Index; Treatment Outcome | 2019 |
Single versus two-treatment schedule of methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face and scalp: An intra-patient randomized trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Drug Administration Schedule; Face; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Patient Satisfaction; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Prospective Studies; Scalp; Sunlight | 2019 |
The impact of occlusive vs non-occlusive application of 5-aminolevulinic acid (BF-200 ALA) on the efficacy and tolerability of photodynamic therapy for actinic keratosis on the scalp and face: A prospective within-patient comparison trial.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Face; Female; Gels; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp | 2021 |
Comparative study of imiquimod 3.75% vs. photodynamic therapy for actinic keratosis of the scalp.
Topics: Aminolevulinic Acid; Humans; Imiquimod; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Scalp; Treatment Outcome | 2021 |
A randomized split-face clinical trial of conventional vs indoor-daylight photodynamic therapy for the treatment of multiple actinic keratosis of the face and scalp and photoaging.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp; Scalp Dermatoses; Skin Aging; Treatment Outcome | 2022 |
Treatment of androgenetic alopecia with 5-aminolevulinic acid photodynamic therapy: A randomized, placebo-controlled, split-scalp study of efficacy and safety.
Topics: Alopecia Areata; Aminolevulinic Acid; Humans; Photochemotherapy; Photosensitizing Agents; Scalp; Treatment Outcome | 2021 |
Randomized controlled trial for evaluation of efficacy and pain during photodynamic therapy for actinic keratosis of face and scalp comparing two irradiation protocols.
Topics: Aminolevulinic Acid; Face; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Scalp; Treatment Outcome | 2022 |
Efficacy of two different methods of cold air analgesia for pain relief in PDT of actinic keratoses of the head region - a randomized controlled comparison study.
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Scalp; Treatment Outcome | 2022 |
28 other study(ies) available for salicylic acid and aminolevulinic acid
| Article | Year |
|---|---|
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |
[Effect of exogenous Ca2+, ALA, SA and Spd on seed germination and physiological characteristics of Perilla frutescens seedlings under NaCl stress].
Topics: Aminolevulinic Acid; Calcium; Catalase; Dose-Response Relationship, Drug; Germination; Malondialdehyde; Perilla frutescens; Peroxidase; Salicylic Acid; Seedlings; Sodium Chloride; Spermidine; Stress, Physiological; Superoxide Dismutase | 2010 |
Cutaneous Rhodotorula treated with photodynamic therapy.
Topics: Aminolevulinic Acid; Antifungal Agents; Dermatomycoses; Humans; Lasers, Dye; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Rhodotorula; Salicylic Acid | 2012 |
Retrospective analysis evaluating the effect of a keratolytic and physical pretreatment with salicylic acid, urea and curettage on the efficacy and safety of photodynamic therapy of actinic keratoses with methylaminolaevulinate.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Salicylic Acid; Urea | 2016 |
Short-term chemical pretreatment cannot replace curettage in photodynamic therapy.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Anti-Inflammatory Agents; Betamethasone; Calcitriol; Curettage; Dermatologic Agents; Drug Therapy, Combination; Female; Fluorescence; Healthy Volunteers; Humans; Keratolytic Agents; Male; Middle Aged; Ointments; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Salicylic Acid; Young Adult | 2016 |
5-Aminolevulinic Acid Dehydratase Gene Dosage Affects Programmed Cell Death and Immunity.
Topics: Aminolevulinic Acid; Apoptosis; Disease Resistance; Gene Dosage; Gossypium; Mutation; Plant Diseases; Plant Proteins; Polyploidy; Porphobilinogen Synthase; Reactive Oxygen Species; Salicylic Acid; Verticillium | 2017 |
Development of malignant melanoma after repeated topical photodynamic therapy with 5-aminolevulinic acid at the exposed site.
Topics: Aged; Aged, 80 and over; Alopecia; Aminolevulinic Acid; Carcinoma, Squamous Cell; Follow-Up Studies; Humans; Keratosis; Male; Melanoma; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms; Sunlight | 1997 |
Treatment of multiple scalp basal cell carcinomas by photodynamic therapy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Female; Follow-Up Studies; Head and Neck Neoplasms; Humans; Neoplasms, Basal Cell; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms; Treatment Outcome | 2001 |
Photodynamic therapy may be useful in debulking cutaneous lymphoma prior to radiotherapy.
Topics: Administration, Topical; Aged; Aminolevulinic Acid; Combined Modality Therapy; Female; Head and Neck Neoplasms; Humans; Lymphoma, Large B-Cell, Diffuse; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms | 2004 |
Photodynamic therapy with methyl aminolevulinate for resistant scalp folliculitis secondary to Demodex infestation.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Animals; Folliculitis; Humans; Male; Mites; Photochemotherapy; Photosensitizing Agents; Scalp | 2009 |
Clearance of a thick invasive squamous cell carcinoma after multiple treatments with topical photodynamic therapy.
Topics: Administration, Topical; Aminolevulinic Acid; Biopsy, Needle; Carcinoma, Squamous Cell; Female; Follow-Up Studies; Humans; Immunohistochemistry; Middle Aged; Neoplasm Invasiveness; Neoplasm Staging; Photochemotherapy; Photosensitizing Agents; Remission Induction; Risk Assessment; Scalp; Skin Neoplasms; Treatment Outcome | 2010 |
Alopecia of the scalp after ineffective treatment of Bowen's disease using red light 5-aminolevulinic acid photodynamic therapy: two case reports.
Topics: Aged; Alopecia; Aminolevulinic Acid; Bowen's Disease; Female; Humans; Mohs Surgery; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms; Treatment Failure; Treatment Outcome | 2010 |
Daylight-mediated photodynamic therapy of basal cell carcinomas - an explorative study.
Topics: Adult; Aged; Aged, 80 and over; Aminolevulinic Acid; Back; Carcinoma, Basal Cell; Facial Neoplasms; Female; Humans; Leg; Male; Middle Aged; Neoplasm Recurrence, Local; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Radiometry; Scalp; Skin Neoplasms; Sunlight; Thorax; Treatment Outcome | 2014 |
Comparative study of trichloroacetic acid vs. photodynamic therapy with topical 5-aminolevulinic acid for actinic keratosis of the scalp.
Topics: Administration, Topical; Aged, 80 and over; Aminolevulinic Acid; Child; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Scalp; Trichloroacetic Acid | 2015 |
Successful treatment of extramammary Paget's disease of the scalp with photodynamic therapy.
Topics: Aged, 80 and over; Aminolevulinic Acid; Head and Neck Neoplasms; Humans; Male; Paget Disease, Extramammary; Photochemotherapy; Photosensitizing Agents; Scalp; Skin Neoplasms | 2016 |
Photodynamic Therapy Effectively Treats Actinic Keratoses Without Pre-Illumination Incubation Time.
Topics: Aminolevulinic Acid; Face; Humans; Keratosis, Actinic; Male; Middle Aged; Pain; Photochemotherapy; Photosensitizing Agents; Protoporphyrins; Scalp; Sunlight; Time Factors; Treatment Outcome | 2017 |
Daylight photodynamic therapy in 25 patients with actinic keratosis and evaluation of efficacy by confocal microscopy.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Face; Female; Humans; Keratosis, Actinic; Male; Microscopy, Confocal; Photochemotherapy; Photosensitizing Agents; Scalp; Severity of Illness Index; Sunlight | 2019 |
Successful Treatment for Extensive Bowen's Disease using Daylight-mediated Photodynamic Therapy.
Topics: Aged, 80 and over; Aminolevulinic Acid; Biopsy, Needle; Bowen's Disease; Follow-Up Studies; Humans; Immunohistochemistry; Male; Neoplasm Invasiveness; Neoplasm Staging; Photochemotherapy; Photoperiod; Risk Assessment; Scalp; Skin Neoplasms; Treatment Outcome | 2019 |
Taking daylight-PDT home.
Topics: Aminolevulinic Acid; Germany; Humans; Keratosis, Actinic; Photochemotherapy; Scalp | 2019 |
Come in from the cold - laser fabric photodynamic therapy offers an alternative to seasonal daylight therapy.
Topics: Aminolevulinic Acid; Forehead; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp; Seasons | 2019 |
Combination of tacalcitol ointment and photodynamic therapy for the treatment of follicular mucinosis of the scalp.
Topics: Alopecia Areata; Aminolevulinic Acid; Dermatologic Agents; Dihydroxycholecalciferols; Drug Therapy, Combination; Female; Humans; Middle Aged; Mucinosis, Follicular; Photochemotherapy; Photosensitizing Agents; Scalp | 2019 |
Successful treatment of kerion with itraconazole and ALA-PDT: A case report.
Topics: Aminolevulinic Acid; Child; Dermatomycoses; Drug Therapy, Combination; Female; Humans; Itraconazole; Photochemotherapy; Photosensitizing Agents; Scalp | 2019 |
Ablative Fractional Laser-assisted Daylight Photodynamic Therapy for Actinic Keratoses of the Scalp and Forehead in Organ Transplant Recipients: A Pilot Study.
Topics: Aged; Aminolevulinic Acid; Female; Forehead; Humans; Keratosis, Actinic; Male; Middle Aged; Photochemotherapy; Photosensitizing Agents; Pilot Projects; Scalp; Transplant Recipients | 2019 |
Combined daylight and conventional photodynamic therapy with 5-aminolaevulinic acid nanoemulsion (BF-200 ALA) for actinic keratosis of the face and scalp: a new and efficient approach.
Topics: Aged; Aged, 80 and over; Aminolevulinic Acid; Face; Female; Humans; Keratosis, Actinic; Light; Male; Middle Aged; Pain; Pain Measurement; Photochemotherapy; Photosensitizing Agents; Retrospective Studies; Scalp; Skin; Treatment Outcome | 2020 |
Clinical, histopathological and immunohistochemical evaluation of daylight photodynamic therapy in the treatment of field cancerization: a study of 30 cases.
Topics: Adult; Aminolevulinic Acid; Humans; Keratosis, Actinic; Photochemotherapy; Photosensitizing Agents; Scalp; Treatment Outcome | 2022 |
No room for pain: A prospective study showing effective and nearly pain-free treatment of actinic keratosis with simulated daylight photodynamic therapy (SDL-PDT) using the IndoorLux® System in combination with BF-200 ALA (Ameluz®).
Topics: Aminolevulinic Acid; Humans; Keratosis, Actinic; Pain; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Treatment Outcome | 2022 |
Aminolevulinic Acid-Photodynamic Therapy for Erosive Pustular Dermatosis of the Scalp: Comparison of Two Treatment Protocols and Participant Satisfaction.
Topics: Aminolevulinic Acid; Clinical Protocols; Humans; Personal Satisfaction; Photochemotherapy; Photosensitizing Agents; Scalp; Scalp Dermatoses | 2022 |
Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
Topics: Aged; Aminolevulinic Acid; Female; Humans; Keratosis, Actinic; Male; Photochemotherapy; Photosensitizing Agents; Prospective Studies; Scalp; Sunlight; Treatment Outcome | 2022 |